Mesothelioma - Articles

Lung Cancer Studies Earn Prestigious Award

Shahriyour Andaz, MD, FACS, FRCS, Director of Thoracic Oncology at South Nassau Communities Hospital, is the co-author of two studies that earned honors at the Brooklyn and Long Island Chapter of the American College of Surgeons Murry Friedman Surgical Resident Competition.

Indoor Residential Air Quality Has Significant Impact On Health

Indoor air quality has a greater impact on health than outdoor air quality, as North American adults spend almost 90% of their time indoors. Exposure to chemical and biological contaminants and possible cancer-causing agents is possible, and can contribute to the risk of developing respiratory and neurologic symptoms, allergies, asthma and lung cancer.

Sex, Death And Rock & Roll - Teen Movie Makers Help Create Cutting Edge Anti-smoking Films

Three hard hitting films - designed by teenagers for teenagers - were launched after a national competition helped uncover the next generation of British film makers. Cancer Research UK and Channel 4's 4Talent launched a joint initiative - funded by the Department of Health - called BREATHE to produce a selection of short online films to encourage young smokers to quit and deter others from starting.

Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine Or Vinorelbine In Performance Status (PS 2) NSCLC Patients

Cell Therapeutics, Inc. (CTI) announced the publication of results from its randomized phase III trial comparing OPAXIO(TM) (paclitaxel poliglumex, CT-2103) with gemcitabine or vinorelbine for the treatment of PS 2 (performance status 2) patients with previously untreated non-small cell lung cancer (NSCLC) in the Journal of Thoracic Oncology (Volume 3, Number 7, July 2008). Results showed that overall survival was similar between the two arms (hazard ratio of 0.

A Report By Leading Clinical Researchers On The Current Quantitative Imaging Tools For Lung Cancer Drug Assessment

Research and Markets has announced the addition of the "Quantitative Imaging Tools for Lung Cancer Drug Assessment" report to their offering.